Figure 4.
Cumulative incidences of CMV reactivation in the first 100 days post-HCT stratified by the last pre-HCT CMV DNA PCR test result. Cumulative incidence curve showing the time to any CMV infection (A,D), time to CMV viral load ≥150 IU/mL (B,E), or time to CMV viral load ≥500 IU/mL (C,F), among PET era patients (n = 1367; A-C) or LET era patients (n = 332; D-F) in the first 100 days after HCT, dependent on the presence (green dashed line), absence (blue solid line), or clearance (red dotted line) of pre-HCT CMV DNAemia. Lighter colored shading indicates the 95% confidence interval. In each graph, the difference between those with any vs no pretransplant CMV PCR detection was calculated using Gray’s test; P values are listed on the right of the graphs.

Cumulative incidences of CMV reactivation in the first 100 days post-HCT stratified by the last pre-HCT CMV DNA PCR test result. Cumulative incidence curve showing the time to any CMV infection (A,D), time to CMV viral load ≥150 IU/mL (B,E), or time to CMV viral load ≥500 IU/mL (C,F), among PET era patients (n = 1367; A-C) or LET era patients (n = 332; D-F) in the first 100 days after HCT, dependent on the presence (green dashed line), absence (blue solid line), or clearance (red dotted line) of pre-HCT CMV DNAemia. Lighter colored shading indicates the 95% confidence interval. In each graph, the difference between those with any vs no pretransplant CMV PCR detection was calculated using Gray’s test; P values are listed on the right of the graphs.

Close Modal

or Create an Account

Close Modal
Close Modal